TrialCancer communications (London, England)2025

Neoadjuvant chemoradiotherapy with capecitabine and irinotecan guided by UGT1A1 status in patients with locally advanced rectal cancer: 5-year update of the CinClare trial.

Zhen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.